NADH Pro Active
Natural health product licensed in Canada
- Other names
- NADH Max, NADH Pro, NADH Pro+
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80139843
- Status
- Active licence
- Licence date
- 3 April 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hordeum vulgare | 100 mg | Not calculated |
| Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D- Source : D-Ribose-L-cystéine | 150 mg | Not calculated |
| Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D- Source : Ribose | 150 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Rhodobacter sphaeroides - Whole | 10 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 10 mg | Not calculated |
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Aspergillus niger - En entier | 1,250 FCC Baker Unit | Not calculated |
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Saccharomyces cerevisiae - en entier | 1,250 FCC Baker Unit | Not calculated |
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Aspergillus niger - En entier | 25 mg | Not calculated |
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Saccharomyces cerevisiae - en entier | 25 mg | Not calculated |
| Dinucléotide de 1,4-dihydronicotinamide adénine | 20 mg | Not calculated |
Non-medicinal ingredients
Phosphatidylcholine hydrogénée, Stéarate de magnésium, farine de riz, Cellulose microcristalline, dérivé sodium-cuivre de la chlorophylline, Hydroxypropylméthylcellulose, Palmitate d'ascorbyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to increase energy production (ATP) at the cellular level. Helps support cognitive health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80139843
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.